GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (TSXV:IPCI) » Definitions » 5-Year Yield-on-Cost %

IntelliPharmaCeutics International (TSXV:IPCI) 5-Year Yield-on-Cost % : 0.00 (As of May. 21, 2024)


View and export this data going back to 1999. Start your Free Trial

What is IntelliPharmaCeutics International 5-Year Yield-on-Cost %?

IntelliPharmaCeutics International's yield on cost for the quarter that ended in Aug. 2023 was 0.00.


The historical rank and industry rank for IntelliPharmaCeutics International's 5-Year Yield-on-Cost % or its related term are showing as below:



TSXV:IPCI's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.615
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of IntelliPharmaCeutics International's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, IntelliPharmaCeutics International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntelliPharmaCeutics International's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's 5-Year Yield-on-Cost % falls into.



IntelliPharmaCeutics International 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of IntelliPharmaCeutics International is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

IntelliPharmaCeutics International  (TSXV:IPCI) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


IntelliPharmaCeutics International 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


IntelliPharmaCeutics International (TSXV:IPCI) Business Description

Traded in Other Exchanges
Address
30 Worcester Road, Toronto, ON, CAN, M9W 5X2
IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.

IntelliPharmaCeutics International (TSXV:IPCI) Headlines

No Headlines